drugset / Trial / NCT02742129

Summary

A randomized, double-blind, placebo-controlled crossover study to assess the effect of inorganic nitrite (NO2) on aerobic capacity (peak VO2) after four weeks of dosing. Approximately 100 participants will be enrolled in this 2\*2 crossover study.

Timeline

Start
2016-08-10
Primary completion
2017-12-13
Completion
2017-12-27

Outcome

Missed primary endpoint

registry p = 0.2650; Mean Difference (Final Values) -0.20 (95% CI -0.56 to 0.16) NCT02742129 ↗

paper there was no significant difference in mean peak oxygen consumption as compared with the placebo phase PMID 30398602 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Nitrite Small molecule 80 mg Inhaled

Indications